Found 126 hits Enz. Inhib. hit(s) with all data for entry = 1938 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347485
(US9790180, ID 019 | US9790180, ID 020)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1 Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347471
(US9790180, ID 005)Show SMILES CN1CCN(CC1)C(=O)N1CCC(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H34N6O2S/c1-32-14-16-34(17-15-32)28(36)33-12-10-23(11-13-33)30-22-7-4-20(5-8-22)27(35)31-25-19-21(6-9-24(25)29)26-3-2-18-37-26/h2-9,18-19,23,30H,10-17,29H2,1H3,(H,31,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347468
(US9790180, ID 004)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H33N5O3S/c1-28(10-12-32(13-11-28)27(35)33-14-16-36-17-15-33)31-22-7-4-20(5-8-22)26(34)30-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,31H,10-17,29H2,1H3,(H,30,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347482
(US9790180, ID 016)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H36N6O2S/c1-29(11-13-34(14-12-29)28(37)35-17-15-33(2)16-18-35)32-23-8-5-21(6-9-23)27(36)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,11-18,30H2,1-2H3,(H,31,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347481
(US9790180, ID 015)Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H34N6O2S/c1-28(10-14-33(15-11-28)27(36)34-16-12-30-13-17-34)32-22-7-4-20(5-8-22)26(35)31-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,30,32H,10-17,29H2,1H3,(H,31,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347485
(US9790180, ID 019 | US9790180, ID 020)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1 Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347490
(US9790180, ID 023)Show SMILES CCC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H36N6O2S/c1-2-29(11-15-34(16-12-29)28(37)35-17-13-31-14-18-35)33-23-8-5-21(6-9-23)27(36)32-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,31,33H,2,11-18,30H2,1H3,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347479
(US9790180, ID 013)Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H33N5O2S/c1-28(12-16-33(17-13-28)27(35)32-14-2-3-15-32)31-22-9-6-20(7-10-22)26(34)30-24-19-21(8-11-23(24)29)25-5-4-18-36-25/h4-11,18-19,31H,2-3,12-17,29H2,1H3,(H,30,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347485
(US9790180, ID 019 | US9790180, ID 020)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1 Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347472
(US9790180, ID 006)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C27H31N5O2S/c28-23-10-7-20(25-4-3-17-35-25)18-24(23)30-26(33)19-5-8-21(9-6-19)29-22-11-15-32(16-12-22)27(34)31-13-1-2-14-31/h3-10,17-18,22,29H,1-2,11-16,28H2,(H,30,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347471
(US9790180, ID 005)Show SMILES CN1CCN(CC1)C(=O)N1CCC(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H34N6O2S/c1-32-14-16-34(17-15-32)28(36)33-12-10-23(11-13-33)30-22-7-4-20(5-8-22)27(35)31-25-19-21(6-9-24(25)29)26-3-2-18-37-26/h2-9,18-19,23,30H,10-17,29H2,1H3,(H,31,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347489
(US9790180, ID 022)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCOCC2)cc1)-c1cccs1 Show InChI InChI=1S/C28H32N4O3S/c29-24-8-5-21(26-2-1-17-36-26)18-25(24)31-27(33)19-3-6-22(7-4-19)30-23-9-13-32(14-10-23)28(34)20-11-15-35-16-12-20/h1-8,17-18,20,23,30H,9-16,29H2,(H,31,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347491
(US9790180, ID 024)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C29H34N4O3S/c30-24-11-8-21(26-5-4-18-37-26)19-25(24)32-27(34)20-6-9-22(10-7-20)31-23-12-16-33(17-13-23)28(35)29(36)14-2-1-3-15-29/h4-11,18-19,23,31,36H,1-3,12-17,30H2,(H,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347455
(US9790180, ID 001)Show SMILES CC(C)NC(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C25H31N7O2S/c1-16(2)29-24(34)32-10-8-25(3,9-11-32)31-23-27-14-18(15-28-23)22(33)30-20-13-17(6-7-19(20)26)21-5-4-12-35-21/h4-7,12-16H,8-11,26H2,1-3H3,(H,29,34)(H,30,33)(H,27,28,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347492
(US9790180, ID 025)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C28H32N4O3S/c29-23-10-7-20(25-4-3-17-36-25)18-24(23)31-26(33)19-5-8-21(9-6-19)30-22-11-15-32(16-12-22)27(34)28(35)13-1-2-14-28/h3-10,17-18,22,30,35H,1-2,11-16,29H2,(H,31,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347459
(US9790180, ID 002)Show SMILES CC(C)C1(CCN(CC1)C(=O)N1CCN(C)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H38N8O2S/c1-20(2)29(8-10-36(11-9-29)28(39)37-14-12-35(3)13-15-37)34-27-31-18-22(19-32-27)26(38)33-24-17-21(6-7-23(24)30)25-5-4-16-40-25/h4-7,16-20H,8-15,30H2,1-3H3,(H,33,38)(H,31,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347497
(US9790180, ID 030)Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O2/c1-29(12-18-35(19-13-29)28(37)34-16-2-3-17-34)33-24-7-4-22(5-8-24)27(36)32-26-20-23(6-9-25(26)30)21-10-14-31-15-11-21/h4-11,14-15,20,33H,2-3,12-13,16-19,30H2,1H3,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347476
(US9790180, ID 010)Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C26H32N8O2S/c1-26(6-10-33(11-7-26)25(36)34-12-8-28-9-13-34)32-24-29-16-19(17-30-24)23(35)31-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17,28H,6-13,27H2,1H3,(H,31,35)(H,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7.30 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347508
(US9790180, ID 040)Show SMILES CN1CCC(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1 Show InChI InChI=1S/C23H26N6O/c1-29-11-9-19(10-12-29)27-23-25-14-18(15-26-23)22(30)28-21-13-17(7-8-20(21)24)16-5-3-2-4-6-16/h2-8,13-15,19H,9-12,24H2,1H3,(H,28,30)(H,25,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347477
(US9790180, ID 011)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347474
(US9790180, ID 008)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C26H31N7O3S/c1-26(6-8-32(9-7-26)25(35)33-10-12-36-13-11-33)31-24-28-16-19(17-29-24)23(34)30-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17H,6-13,27H2,1H3,(H,30,34)(H,28,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347497
(US9790180, ID 030)Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O2/c1-29(12-18-35(19-13-29)28(37)34-16-2-3-17-34)33-24-7-4-22(5-8-24)27(36)32-26-20-23(6-9-25(26)30)21-10-14-31-15-11-21/h4-11,14-15,20,33H,2-3,12-13,16-19,30H2,1H3,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 9.40 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347493
(US9790180, ID 026)Show SMILES CN1CCC(CC1)(Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1)c1ccccc1 Show InChI InChI=1S/C27H28N6OS/c1-33-13-11-27(12-14-33,21-6-3-2-4-7-21)32-26-29-17-20(18-30-26)25(34)31-23-16-19(9-10-22(23)28)24-8-5-15-35-24/h2-10,15-18H,11-14,28H2,1H3,(H,31,34)(H,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347481
(US9790180, ID 015)Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H34N6O2S/c1-28(10-14-33(15-11-28)27(36)34-16-12-30-13-17-34)32-22-7-4-20(5-8-22)26(35)31-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,30,32H,10-17,29H2,1H3,(H,31,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347496
(US9790180, ID 029)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347484
(US9790180, ID 018)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N1CCCC11CCN(CC1)C(=O)N1CCCC1)-c1cccs1 Show InChI InChI=1S/C28H33N7O2S/c29-22-7-6-20(24-5-3-16-38-24)17-23(22)32-25(36)21-18-30-26(31-19-21)35-13-4-8-28(35)9-14-34(15-10-28)27(37)33-11-1-2-12-33/h3,5-7,16-19H,1-2,4,8-15,29H2,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347482
(US9790180, ID 016)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H36N6O2S/c1-29(11-13-34(14-12-29)28(37)35-17-15-33(2)16-18-35)32-23-8-5-21(6-9-23)27(36)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,11-18,30H2,1-2H3,(H,31,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347509
(US9790180, ID 041)Show SMILES CC1(CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1 Show InChI InChI=1S/C23H26N6O/c1-23(9-11-25-12-10-23)29-22-26-14-18(15-27-22)21(30)28-20-13-17(7-8-19(20)24)16-5-3-2-4-6-16/h2-8,13-15,25H,9-12,24H2,1H3,(H,28,30)(H,26,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347479
(US9790180, ID 013)Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H33N5O2S/c1-28(12-16-33(17-13-28)27(35)32-14-2-3-15-32)31-22-9-6-20(7-10-22)26(34)30-24-19-21(8-11-23(24)29)25-5-4-18-36-25/h4-11,18-19,31H,2-3,12-17,29H2,1H3,(H,30,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347488
(US9790180, ID 021)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347467
(US9790180, ID 003)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCOCC2)nc1)-c1cccs1 Show InChI InChI=1S/C25H29N7O3S/c26-20-4-3-17(22-2-1-13-36-22)14-21(20)30-23(33)18-15-27-24(28-16-18)29-19-5-7-31(8-6-19)25(34)32-9-11-35-12-10-32/h1-4,13-16,19H,5-12,26H2,(H,30,33)(H,27,28,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347507
(US9790180, ID 039)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNCC2)nc1)-c1ccccc1 Show InChI InChI=1S/C22H24N6O/c23-19-7-6-16(15-4-2-1-3-5-15)12-20(19)28-21(29)17-13-25-22(26-14-17)27-18-8-10-24-11-9-18/h1-7,12-14,18,24H,8-11,23H2,(H,28,29)(H,25,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347500
(US9790180, ID 032)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1ccncc1 Show InChI InChI=1S/C28H32N6O2/c29-25-8-5-22(20-9-13-30-14-10-20)19-26(25)32-27(35)21-3-6-23(7-4-21)31-24-11-17-34(18-12-24)28(36)33-15-1-2-16-33/h3-10,13-14,19,24,31H,1-2,11-12,15-18,29H2,(H,32,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347485
(US9790180, ID 019 | US9790180, ID 020)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1 Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347496
(US9790180, ID 029)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347489
(US9790180, ID 022)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCOCC2)cc1)-c1cccs1 Show InChI InChI=1S/C28H32N4O3S/c29-24-8-5-21(26-2-1-17-36-26)18-25(24)31-27(33)19-3-6-22(7-4-19)30-23-9-13-32(14-10-23)28(34)20-11-15-35-16-12-20/h1-8,17-18,20,23,30H,9-16,29H2,(H,31,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347483
(US9790180, ID 017)Show SMILES CCC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H35N5O3S/c1-2-29(11-13-33(14-12-29)28(36)34-15-17-37-18-16-34)32-23-8-5-21(6-9-23)27(35)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,2,11-18,30H2,1H3,(H,31,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347478
(US9790180, ID 012)Show SMILES CC1(CCN(CC1)C(=O)N1CCC(F)(F)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C27H31F2N7O2S/c1-26(6-10-35(11-7-26)25(38)36-12-8-27(28,29)9-13-36)34-24-31-16-19(17-32-24)23(37)33-21-15-18(4-5-20(21)30)22-3-2-14-39-22/h2-5,14-17H,6-13,30H2,1H3,(H,33,37)(H,31,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347490
(US9790180, ID 023)Show SMILES CCC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H36N6O2S/c1-2-29(11-15-34(16-12-29)28(37)35-17-13-31-14-18-35)33-23-8-5-21(6-9-23)27(36)32-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,31,33H,2,11-18,30H2,1H3,(H,32,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347500
(US9790180, ID 032)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1ccncc1 Show InChI InChI=1S/C28H32N6O2/c29-25-8-5-22(20-9-13-30-14-10-20)19-26(25)32-27(35)21-3-6-23(7-4-21)31-24-11-17-34(18-12-24)28(36)33-15-1-2-16-33/h3-10,13-14,19,24,31H,1-2,11-12,15-18,29H2,(H,32,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347468
(US9790180, ID 004)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C28H33N5O3S/c1-28(10-12-32(13-11-28)27(35)33-14-16-36-17-15-33)31-22-7-4-20(5-8-22)26(34)30-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,31H,10-17,29H2,1H3,(H,30,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347472
(US9790180, ID 006)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C27H31N5O2S/c28-23-10-7-20(25-4-3-17-35-25)18-24(23)30-26(33)19-5-8-21(9-6-19)29-22-11-15-32(16-12-22)27(34)31-13-1-2-14-31/h3-10,17-18,22,29H,1-2,11-16,28H2,(H,30,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347503
(US9790180, ID 035)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1 Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347491
(US9790180, ID 024)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C29H34N4O3S/c30-24-11-8-21(26-5-4-18-37-26)19-25(24)32-27(34)20-6-9-22(10-7-20)31-23-12-16-33(17-13-23)28(35)29(36)14-2-1-3-15-29/h4-11,18-19,23,31,36H,1-3,12-17,30H2,(H,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347476
(US9790180, ID 010)Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C26H32N8O2S/c1-26(6-10-33(11-7-26)25(36)34-12-8-28-9-13-34)32-24-29-16-19(17-30-24)23(35)31-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17,28H,6-13,27H2,1H3,(H,31,35)(H,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347509
(US9790180, ID 041)Show SMILES CC1(CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1 Show InChI InChI=1S/C23H26N6O/c1-23(9-11-25-12-10-23)29-22-26-14-18(15-27-22)21(30)28-20-13-17(7-8-19(20)24)16-5-3-2-4-6-16/h2-8,13-15,25H,9-12,24H2,1H3,(H,28,30)(H,26,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347492
(US9790180, ID 025)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C28H32N4O3S/c29-23-10-7-20(25-4-3-17-36-25)18-24(23)31-26(33)19-5-8-21(9-6-19)30-22-11-15-32(16-12-22)27(34)28(35)13-1-2-14-28/h3-10,17-18,22,30,35H,1-2,11-16,29H2,(H,31,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347459
(US9790180, ID 002)Show SMILES CC(C)C1(CCN(CC1)C(=O)N1CCN(C)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C29H38N8O2S/c1-20(2)29(8-10-36(11-9-29)28(39)37-14-12-35(3)13-15-37)34-27-31-18-22(19-32-27)26(38)33-24-17-21(6-7-23(24)30)25-5-4-16-40-25/h4-7,16-20H,8-15,30H2,1-3H3,(H,33,38)(H,31,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347477
(US9790180, ID 011)Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1 Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347475
(US9790180, ID 009)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCCCC2)nc1)-c1cccs1 Show InChI InChI=1S/C26H31N7O2S/c27-21-7-6-18(23-5-4-14-36-23)15-22(21)31-24(34)19-16-28-25(29-17-19)30-20-8-12-33(13-9-20)26(35)32-10-2-1-3-11-32/h4-7,14-17,20H,1-3,8-13,27H2,(H,31,34)(H,28,29,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Search and Browse
